FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386461698> ?p ?o ?g. }

• W4386461698 abstract "Abstract Background Triple negative breast cancer (TNBC) is a major subtype of breast cancer, with limited therapeutic drugs in clinical. Epidermal growth factor receptor (EGFR) is reported to be overexpressed in various TNBC cells. Cantharidin is an effective ingredient in many clinical traditional Chinese medicine preparations, such as Delisheng injection, Aidi injection, Disodium cantharidinate and vitamin B6 injection. Previous studies showed that cantharidin had satisfactory pharmacological activity on a variety of tumors. In this study, we aimed to study the therapeutic potential of cantharidin for TNBC treatment by targeting EGFR, and expound its novel regulator miR-607. Methods The effect of cantharidin on breast cancer in vivo was evaluated by 4T1 mice model. Then the effects of cantharidin on TNBC cells was assessed by the MTT, colony formation, and AnnexinV-PE/7AAD staining. Cantharidin acts on EGFR were verified using the cell membrane chromatography, RT-PCR, Western blotting, MTT, and so on. Mechanistic studies were explored by dual-luciferase report assay, RT-PCR, western blotting, and immunofluorescence staining assay. Results Cantharidin inhibited TNBC cell growth and induce apoptosis by targeting EGFR. miR-607 was a novel EGFR regulator and exhibited suppressive functions on TNBC cell behaviors. Mechanistic study showed that cantharidin blocked the downstream PI3K/AKT/mTOR and ERK/MAPK signaling pathway. Conclusion Our results revealed that cantharidin may be served as a potential candidate for TNBC treatment by miR-607-mediated downregulation of EGFR. Graphical Abstract" @default.
• W4386461698 created "2023-09-06" @default.
• W4386461698 creator A5003318665 @default.
• W4386461698 creator A5011860975 @default.
• W4386461698 creator A5020088480 @default.
• W4386461698 creator A5034330994 @default.
• W4386461698 creator A5034940004 @default.
• W4386461698 creator A5056035280 @default.
• W4386461698 creator A5076265557 @default.
• W4386461698 creator A5077484278 @default.
• W4386461698 creator A5091410060 @default.
• W4386461698 date "2023-09-05" @default.
• W4386461698 modified "2023-09-28" @default.
• W4386461698 title "Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR" @default.
• W4386461698 cites W1857266517 @default.
• W4386461698 cites W2011826559 @default.
• W4386461698 cites W2024014087 @default.
• W4386461698 cites W2024028023 @default.
• W4386461698 cites W2028415754 @default.
• W4386461698 cites W2063432148 @default.
• W4386461698 cites W2071697907 @default.
• W4386461698 cites W2302301703 @default.
• W4386461698 cites W2402636472 @default.
• W4386461698 cites W2518718875 @default.
• W4386461698 cites W2559821614 @default.
• W4386461698 cites W2560836545 @default.
• W4386461698 cites W2766170561 @default.
• W4386461698 cites W2782821792 @default.
• W4386461698 cites W2788106879 @default.
• W4386461698 cites W2801840611 @default.
• W4386461698 cites W2804039955 @default.
• W4386461698 cites W2808219623 @default.
• W4386461698 cites W2888772173 @default.
• W4386461698 cites W2890611180 @default.
• W4386461698 cites W2915802504 @default.
• W4386461698 cites W2921100812 @default.
• W4386461698 cites W2931077265 @default.
• W4386461698 cites W3119005666 @default.
• W4386461698 cites W3154563477 @default.
• W4386461698 cites W3173228099 @default.
• W4386461698 cites W3206857501 @default.
• W4386461698 cites W4211075026 @default.
• W4386461698 doi "https://doi.org/10.1186/s12967-023-04483-y" @default.
• W4386461698 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37670360" @default.
• W4386461698 hasPublicationYear "2023" @default.
• W4386461698 type Work @default.
• W4386461698 citedByCount "0" @default.
• W4386461698 crossrefType "journal-article" @default.
• W4386461698 hasAuthorship W4386461698A5003318665 @default.
• W4386461698 hasAuthorship W4386461698A5011860975 @default.
• W4386461698 hasAuthorship W4386461698A5020088480 @default.
• W4386461698 hasAuthorship W4386461698A5034330994 @default.
• W4386461698 hasAuthorship W4386461698A5034940004 @default.
• W4386461698 hasAuthorship W4386461698A5056035280 @default.
• W4386461698 hasAuthorship W4386461698A5076265557 @default.
• W4386461698 hasAuthorship W4386461698A5077484278 @default.
• W4386461698 hasAuthorship W4386461698A5091410060 @default.
• W4386461698 hasBestOaLocation W43864616981 @default.
• W4386461698 hasConcept C104317684 @default.
• W4386461698 hasConcept C121608353 @default.
• W4386461698 hasConcept C126322002 @default.
• W4386461698 hasConcept C127561419 @default.
• W4386461698 hasConcept C178790620 @default.
• W4386461698 hasConcept C185592680 @default.
• W4386461698 hasConcept C190283241 @default.
• W4386461698 hasConcept C2780110267 @default.
• W4386461698 hasConcept C2780783641 @default.
• W4386461698 hasConcept C2780906345 @default.
• W4386461698 hasConcept C502942594 @default.
• W4386461698 hasConcept C530470458 @default.
• W4386461698 hasConcept C55493867 @default.
• W4386461698 hasConcept C57074206 @default.
• W4386461698 hasConcept C62112901 @default.
• W4386461698 hasConcept C62478195 @default.
• W4386461698 hasConcept C71924100 @default.
• W4386461698 hasConcept C75217442 @default.
• W4386461698 hasConcept C86554907 @default.
• W4386461698 hasConcept C86803240 @default.
• W4386461698 hasConcept C95444343 @default.
• W4386461698 hasConcept C98274493 @default.
• W4386461698 hasConceptScore W4386461698C104317684 @default.
• W4386461698 hasConceptScore W4386461698C121608353 @default.
• W4386461698 hasConceptScore W4386461698C126322002 @default.
• W4386461698 hasConceptScore W4386461698C127561419 @default.
• W4386461698 hasConceptScore W4386461698C178790620 @default.
• W4386461698 hasConceptScore W4386461698C185592680 @default.
• W4386461698 hasConceptScore W4386461698C190283241 @default.
• W4386461698 hasConceptScore W4386461698C2780110267 @default.
• W4386461698 hasConceptScore W4386461698C2780783641 @default.
• W4386461698 hasConceptScore W4386461698C2780906345 @default.
• W4386461698 hasConceptScore W4386461698C502942594 @default.
• W4386461698 hasConceptScore W4386461698C530470458 @default.
• W4386461698 hasConceptScore W4386461698C55493867 @default.
• W4386461698 hasConceptScore W4386461698C57074206 @default.
• W4386461698 hasConceptScore W4386461698C62112901 @default.
• W4386461698 hasConceptScore W4386461698C62478195 @default.
• W4386461698 hasConceptScore W4386461698C71924100 @default.
• W4386461698 hasConceptScore W4386461698C75217442 @default.
• W4386461698 hasConceptScore W4386461698C86554907 @default.
• W4386461698 hasConceptScore W4386461698C86803240 @default.

• next